Vitiligo in a Patient Treated with Interferon Alpha-2a for Behcet's Disease

被引：4
|
作者：
Guney, Esra [1 ]
Akcali, Gulunay [1 ]
Akcay, Betul Ilkay [1 ]
Unlu, Cihan [1 ]
Erdogan, Gurkan [1 ]
Bozkurt, Tahir Kansu [1 ]
Bayramlar, Huseyin [1 ]
机构：
[1] Umraniye Res & Educ Hosp, Ophthalmol Clin, Istanbul, Turkey
来源：
CASE REPORTS IN MEDICINE | 2012年 / 2012卷
关键词：
D O I：
10.1155/2012/387140
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Behcet's disease (BD) and vitiligo are diseases of unknown etiology. Interferon (IFN) alpha therapy is commonly used in Behcet uveitis. Interferon treatment in various diseases have also been observed causing certain autoimmune diseases such as vitiligo because of its immunomodulatory activity. The association between IFN therapy and vitiligo has been reported in the literature. We report a 21-year-old man with BD in whom vitiligo occurred during IFN treatment. To the best of our knowledge, this is the first reported case of such an association.
引用
收藏
页数：3
相关论文
共 50 条
  • [31] TREATMENT OF ESSENTIAL THROMBOCYTHEMIA BY ALPHA-2A INTERFERON
    BELLUCCI, S
    HAROUSSEAU, JL
    BRICE, P
    TOBELEM, G
    LANCET, 1988, 2 (8617): : 960 - 961
  • [32] Interferon alpha-2a monotherapy for necrobiotic xanthogranuloma
    Georgiou, S
    Monastirli, A
    Kapranos, N
    Pasmatzi, E
    Sakkis, T
    Tsambaos, D
    ACTA DERMATO-VENEREOLOGICA, 1999, 79 (06) : 484 - 485
  • [33] Alpha-interferon (IFN-alpha) treatment Behcet's disease (BD).
    ODuffy, JD
    Matteson, E
    Calamia, K
    Cohen, S
    Jorizzo, J
    Herman, D
    Goronzy, J
    Kokmen, E
    Weyand, C
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1198 - 1198
  • [34] Efficacy of Interferon-Alpha in Behcet Disease
    Saddik, T.
    Kilmartin, D.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2015, 184 : 462 - 462
  • [35] Therapy of ocular manifestations in Behcet's disease (BD) with interferon alpha (IFN alpha)
    Kotter, I
    Eckstein, A
    Zierhut, M
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (03) : 4755 - 4755
  • [36] Treatment of herpes zoster with interferon alpha-2a
    Naoum, C
    Perissios, A
    Varnavas, V
    Lagos, D
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1996, 35 (10) : 749 - 750
  • [37] METASTATIC RENAL-CELL CANCER TREATED WITH RECOMBINANT ALPHA-2A INTERFERON AND VINBLASTINE
    MASSIDDA, B
    MIGLIARI, R
    PADOVANI, A
    SCARPA, RM
    PELLEGRINI, P
    CORTESI, E
    USAI, E
    PELLEGRINI, A
    JOURNAL OF CHEMOTHERAPY, 1991, 3 (06) : 387 - 389
  • [38] CHANGES IN DIFFERENTIATION ANTIGENS IN BASAL-CELL CARCINOMA TREATED BY ALPHA-2A INTERFERON
    HESSE, S
    REANO, A
    GROB, JJ
    THIVOLET, J
    BONERANDI, JJ
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1990, 94 (03) : 397 - 397
  • [39] Cyclosporin A as an adjunct may enhance the therapeutic effect of interferon alpha-2a in patients with refractory Behcet's uveitis: a retrospective cohort study
    Yang, Peizeng
    Deng, Yang
    Zhang, Yinan
    Zhu, Yunyun
    Huang, Ziqian
    Dai, Lingyu
    Wu, Qiuying
    Su, Guannan
    Cao, Qingfeng
    Lai, Yujie
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2024, 15
  • [40] Long-term effects of interferon alpha 2A treatment in Behcet's disease
    Boyvat, A
    Sisman-Solak, C
    Gürler, A
    DERMATOLOGY, 2000, 201 (01) : 40 - 43
12345